Lexpos News

/Lexpos News

Community Pharmacy England makes submission to NHS review

Community Pharmacy England has set out the value, challenges and opportunities for the sector in its submission to Lord Darzi’s review of the NHS. The independent investigation of NHS performance, commissioned by the Secretary of State for Health and Social Care, is examining the challenges facing the healthcare system ahead of the development of a [...]

The post Community Pharmacy England makes submission to NHS review appeared first on Community Pharmacy England.

By |August 13th, 2024|Lexpos News|Comments Off on Community Pharmacy England makes submission to NHS review

Help raise awareness of pharmacy issues: Invite your MP to visit

Pharmacy owners and LPCs are encouraged to make use of the current break in Parliamentary activity to engage with their local MPs. Following the General Election, Community Pharmacy England has contacted all new and returning MPs of English constituencies to congratulate them on their respective election victories and seek their support for pharmacy over the [...]

The post Help raise awareness of pharmacy issues: Invite your MP to visit appeared first on Community Pharmacy England.

By |August 12th, 2024|Lexpos News|Comments Off on Help raise awareness of pharmacy issues: Invite your MP to visit

MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)

Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Drug alert number: EL (24)A/36 Date issued: 12 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Company name: Star Pharmaceuticals Limited Product name: Diflucan Oral [...]

The post MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |August 12th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)

Rivaroxaban tablets – changes to reimbursement from September 2024

Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared [...]

The post Rivaroxaban tablets – changes to reimbursement from September 2024 appeared first on Community Pharmacy England.

By |August 9th, 2024|Lexpos News|Comments Off on Rivaroxaban tablets – changes to reimbursement from September 2024

Community Pharmacy England presents strategy to improve outlook for pharmacy

A recorded presentation on what lies ahead for community pharmacy – including Community Pharmacy England’s strategy to improve the outlook for pharmacy owners and their teams – is now available to watch on-demand. Spring 2024 saw two key moments for community pharmacy: the end of the five-year CPCF and a General Election campaign. As critical [...]

The post Community Pharmacy England presents strategy to improve outlook for pharmacy appeared first on Community Pharmacy England.

By |August 9th, 2024|Lexpos News|Comments Off on Community Pharmacy England presents strategy to improve outlook for pharmacy